

Author: Budhoo M.R. Harris R.P. Kellum J.M.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.298, Iss.2, 1996-03, pp. : 137-144
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Ito C. Kawamura R. Isobe Y. Tsuchida K. Muramatsu M. Higuchi S.
General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. :




Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 1, 2004-02 ,pp. :




Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 1, 2004-02 ,pp. :